Oculocerebrocutaneous Syndrome
Symptoms, Doctors, Treatments, Advances & More

Oculocerebrocutaneous Syndrome Overview

Save information for later
Sign Up

Learn About Oculocerebrocutaneous Syndrome

What is the definition of Oculocerebrocutaneous Syndrome?
Oculocerebrocutaneous (OCC) syndrome is a rare genetic disorder characterized primarily by eye, skin, and brain malformations. It has been described mostly in males. Findings in affected individuals may include orbital cysts, areas of underdeveloped (hypoplastic) or absent (aplastic) skin, and underdevelopment (hypoplasia) or absence (agenesis) of the band of nerve fibers that joins the brain's hemispheres (corpus callosum). Diagnosis is confirmed on the basis of specific MRI findings. In some affected individuals, the eye, skin, and brain findings involve only one side of the body. In these cases, the left side is involved twice as often as the right side. Additional findings may include rib and vertebral anomalies and craniofacial anomalies. Developmental delay and intellectual disability may be present and can vary from mild to profound. Approximately 50% of affected individuals have seizures. The exact cause of OCC syndrome is not known. In most cases, the affected individual is the first person in the family to have the disorder.
What are the alternative names for Oculocerebrocutaneous Syndrome?
  • Oculocerebrocutaneous syndrome
  • Delleman Oorthuys syndrome
  • Delleman syndrome
  • OCC Syndrome
  • OCCS
  • Oculo-cerebro-cutaneous syndrome
  • Orbital cyst with cerebral and focal dermal malformations
Who are the top Oculocerebrocutaneous Syndrome Local Doctors?
Distinguished in Oculocerebrocutaneous Syndrome
Distinguished in Oculocerebrocutaneous Syndrome
Referral may be required
Ibadan, OY, NG 

Oluyemi Fasina practices practicing medicine in Ibadan, Nigeria. Mr. Fasina is rated as a Distinguished expert by MediFind in the treatment of Oculocerebrocutaneous Syndrome. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Oculocerebrocutaneous Syndrome, Chemosis, Lacrimal Gland Tumor, and Retinoblastoma.

Distinguished in Oculocerebrocutaneous Syndrome
Distinguished in Oculocerebrocutaneous Syndrome
Referral may be required
Mount Sinai Hospital, 
Toronto, ON, CA 

Susan Blaser practices practicing medicine in Toronto, Canada. Ms. Blaser is rated as a Distinguished expert by MediFind in the treatment of Oculocerebrocutaneous Syndrome. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Oculocerebrocutaneous Syndrome, Orbital Cellulitis, Cerebelloparenchymal Disorder 3, and X-Linked Chondrodysplasia Punctata 2.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Oculocerebrocutaneous Syndrome
Dr. William B. Dobyns
Pediatrics | Neurology | Medical Genetics
Advanced in Oculocerebrocutaneous Syndrome
Dr. William B. Dobyns
Pediatrics | Neurology | Medical Genetics
Referral may be required

M Health Fairview Explorer Pediatric Specialty Clinic

2450 Riverside Avenue, Floor 12, 
Minneapolis, MN 
612-365-6777
Experience:
48+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Dobyns is a Pediatrics specialist and a Neurologist practicing medicine in Minneapolis, Minnesota. He has been practicing medicine for over 48 years. Dr. Dobyns is rated as an Advanced provider by MediFind in the treatment of Oculocerebrocutaneous Syndrome. He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses Increased Head Circumference, Lissencephaly, Cerebellar Hypoplasia, and Cortical Dysplasia. Dr. Dobyns is board certified in Clinical Genetics And Genomics: American Board Of Medical Genetics And Genomics, 1987. Dr. Dobyns is currently accepting new patients.

View All Doctors
What are the latest Oculocerebrocutaneous Syndrome Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center